IRIS
VERDOIA, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.935
EU - Europa 3.128
AS - Asia 2.001
SA - Sud America 345
Continente sconosciuto - Info sul continente non disponibili 215
AF - Africa 45
OC - Oceania 4
Totale 9.673
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.810
RU - Federazione Russa 815
IE - Irlanda 650
SG - Singapore 560
CN - Cina 524
DE - Germania 483
SE - Svezia 336
HK - Hong Kong 310
VN - Vietnam 288
UA - Ucraina 261
BR - Brasile 252
FR - Francia 153
IT - Italia 142
IN - India 132
GB - Regno Unito 97
FI - Finlandia 84
CA - Canada 52
MX - Messico 37
AR - Argentina 33
IR - Iran 33
BD - Bangladesh 29
PL - Polonia 28
ID - Indonesia 27
ZA - Sudafrica 19
NL - Olanda 17
EC - Ecuador 16
ES - Italia 16
JP - Giappone 15
IQ - Iraq 14
CO - Colombia 12
PY - Paraguay 12
CZ - Repubblica Ceca 9
JM - Giamaica 9
KR - Corea 9
AT - Austria 8
PH - Filippine 8
TR - Turchia 8
VE - Venezuela 8
IL - Israele 7
LT - Lituania 7
UZ - Uzbekistan 7
CL - Cile 5
CR - Costa Rica 5
HN - Honduras 5
MA - Marocco 5
UY - Uruguay 5
BE - Belgio 4
DZ - Algeria 4
EG - Egitto 4
PK - Pakistan 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AU - Australia 3
EU - Europa 3
JO - Giordania 3
KZ - Kazakistan 3
PR - Porto Rico 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BJ - Benin 2
CW - ???statistics.table.value.countryCode.CW??? 2
EE - Estonia 2
NG - Nigeria 2
OM - Oman 2
SA - Arabia Saudita 2
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
KG - Kirghizistan 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MV - Maldive 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RO - Romania 1
SC - Seychelles 1
SI - Slovenia 1
Totale 9.459
Salva come PNG Salva come JPEG
Città #
Dublin 650
Jacksonville 504
San Jose 487
Hong Kong 310
Dearborn 248
Ashburn 223
Singapore 210
Council Bluffs 171
Wilmington 169
Beijing 160
Moscow 120
Columbus 101
Chandler 97
Lawrence 87
Princeton 86
Los Angeles 83
Bremen 80
Lauterbourg 78
Ho Chi Minh City 72
Phoenix 58
Hanoi 56
New York 53
Santa Clara 52
Düsseldorf 41
Buffalo 38
San Mateo 37
São Paulo 35
Orem 30
Redondo Beach 28
Ann Arbor 23
Munich 23
Denver 22
North Bergen 22
Dallas 20
Dong Ket 20
Frankfurt am Main 20
Houston 20
Mexico City 19
Warsaw 19
Woodbridge 19
Haiphong 18
Leawood 18
Andover 17
Monmouth Junction 17
Brooklyn 16
Atlanta 15
Chennai 15
Chicago 15
Hefei 15
Johannesburg 15
Montreal 15
Nanjing 15
Guangzhou 14
Manchester 14
Norwalk 14
Poplar 14
Tokyo 14
Ardabil 13
Bexley 13
Helsinki 13
Kunming 13
Piemonte 13
Torino 13
Seattle 12
Fairfield 11
Tianjin 11
Toronto 11
Biên Hòa 10
Augusta 9
Boston 9
Brno 9
Hangzhou 9
Milan 9
Rome 9
Seoul 9
Stockholm 9
Zanjan 9
Amsterdam 8
Da Nang 8
Jakarta 8
Jinan 8
New Delhi 8
Nuremberg 8
San Francisco 8
Kingston 7
Novara 7
Shenyang 7
Tashkent 7
Belo Horizonte 6
London 6
Mumbai 6
Ottawa 6
Philadelphia 6
Quito 6
Sacramento 6
Shenzhen 6
Turku 6
Ankara 5
Baghdad 5
Guayaquil 5
Totale 5.219
Salva come PNG Salva come JPEG
Nome #
Modulation of 1,25(OH)2D levels in cardiovascular system. Genetic regulation, impact on coronary artery disease, inflammation, platelet function and periprocedural myocardial injury after percutaneous coronary interventions 193
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 158
Impact of gender difference on vitamin D status and its relationship with the extent of coronary artery disease 147
Mean platelet volume is not associated with platelet reactivity and the extent of coronary artery disease in diabetic patients 147
Cholecalciferol levels, inflammation and leukocytes parameters: Results from a large single-centre cohort of patients 141
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 139
Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols 138
Platelet PIA1/PIA2 polymorphism and the risk of periprocedural myocardial infarction in patients with acute coronary syndromes undergoing coronary angioplasty. 136
Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study 135
Impact of diabetes on neutrophil-to-lymphocyte ratio and its relationship to coronary artery disease 133
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor. 133
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor: Reply 133
Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor 132
Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity 131
Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty A meta-analyis of randomised trials 129
Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients 129
Aspirin desensitization in patients undergoing planned or urgent coronary stent implantation. A single-center experience. 127
Platelet HPA-1 a/HPA-1 b polymorphism and the risk of periprocedural myocardial infarction in patients undergoing elective PCI. 126
Advanced age and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 126
Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results from a Large Cohort Study 126
Impact of metabolic syndrome on mean platelet volume and its relationship with coronary artery disease 126
Haemoglobin levels do not correlate with the extent of coronary artery disease: results from a large cohort study. 125
Absolute eosinophils count and the extent of coronary artery disease: a single centre cohort study. 124
Impact of long-term dual antiplatelet therapy on immature platelet count and platelet reactivity. 124
Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients 124
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 123
Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor 123
Impact of age on mean platelet volume and its relationship with coronary artery disease: A single-centre cohort study 122
Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor 122
Glycosylated hemoglobin and the risk of periprocedural myocardial infarction in non-diabetic patients 121
Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. 121
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease. 120
Impact of Diabetes on Homocysteine Levels and Its Relationship with Coronary Artery Disease: A Single-Centre Cohort Study 118
Dual Versus Single Antiplatelet Regimen With or Without Anticoagulation in Transcatheter Aortic Valve Replacement: Indirect Comparison and Meta-analysis 117
Duration of dual antiplatelet therapy and outcome in patients with acute coronary syndrome undergoing percutaneous revascularization: A meta-analysis of 11 randomized trials 117
Bivalirudin as compared to unfractionated heparin in patients undergoing percutaneous coronary revascularization: A meta-analysis of 22 randomized trials 116
Association between high-residual platelet reactivity in patients receiving dual antiplatelet therapy, Vitamin D plasma levels and Vitamin D Binding Protein rs7041 polymorphism. 114
Platelet-larger cell ratio and the risk of periprocedural myocardial infarction after percutaneous coronary revascularization. 114
Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease 113
Impact of increasing dose of intracoronary adenosine on peak hyperemia duration during fractional flow reserve assessment 112
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 111
Relationship Between Glycoprotein IIIa Platelet Receptor Gene Polymorphism and Coronary Artery Disease 110
Immature platelet fraction and the extent of coronary artery disease: a single centre study. 110
Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes 109
Randomized evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: Rationale and design of the REDUCE trial 109
Radial vs femoral approach in acute coronary syndromes: A meta-analysis of randomized trials 108
Impact of diabetes on fibrinogen levels and its relationship with platelet reactivity and coronary artery disease: A single-centre study 105
Immature platelet fraction and the extent of coronary artery disease: A single centre study 105
High-Density Lipoproteins and Coronary Artery Disease: A Single-Center Cohort Study 105
Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance. Response 104
Homocysteine levels influence platelet reactivity in coronary artery disease patients treated with acetylsalicylic acid. 103
Impact of long-term therapy with acetylsalicylic acid on immature platelet count: a single-centre cohort study 103
Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation. 102
Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials 102
Risk and Benefits of Triple Therapy in Patients Undergoing Coronary Stent Implantation Requiring Oral Anticoagulation: A Meta-Analysis of 16 Studies 101
Optical coherence tomography guidance during bioresorbable vascular scaffold implantation 101
Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy 101
Effects of HDL-modifiers on cardiovascular outcomes: A meta-analysis of randomized trials. 100
Impact of red blood cells count and high density lipoproteins with the prevalence and extent of coronary artery disease 99
Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study 98
Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy 96
Impact of polymorphism rs7041 and rs4588 of Vitamin D Binding Protein on the extent of coronary artery disease 95
Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy 94
Platelet glycoprotein IIIa Leu33Pro gene polymorphism and coronary artery disease: A meta-analysis of cohort studies. 92
Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy 92
Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor 90
Lipoprotein associated- phospholipase A2 in STEMI vs. NSTE-ACS patients: a marker of cardiovascular atherosclerotic risk rather than thrombosis 89
Impact of sex on uric acid levels and its relationship with the extent of coronary artery disease: A single-centre study 89
Statins and elderly: From clinical trials to daily practice 89
Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban. 88
Vitamin D deficiency and periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions 88
Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment 87
Targeted therapies in non–small cell lung cancer and their cardiovascular impact: mechanisms, clinical profiles, and strategies of management 86
Short-term effects of aspirin and clopidogrel on mean platelet volume among patients with acute coronary syndromes. A single-center prospective study. 86
Two catheters for one perforation 83
Impact of aging on immature platelet count and its relationship with coronary artery disease 82
Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials 81
Vitamin D deficiency is associated with impaired reperfusion in STEMI patients undergoing primary percutaneous coronary intervention 79
Elevated Homocysteine and the Risk of Contrast-Induced Nephropathy: A Cohort Study. 78
Impact of active smoking on the immature platelet fraction and its relationship with the extent of coronary artery disease 77
Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy 76
Switching from Clopidogrel to Prasugrel in patients undergoing PCI: A meta-analytic overview 74
Percutaneous Versus Surgical Revascularization for Left Main or Multivessel Coronary Artery Disease: Results From a Large-Scale Meta-Analysis in the Era of Drug-Eluting Stents 74
Impact of vascular access on the development of contrast induced nephropathy in patients undergoing coronary angiography and/or percutaneous coronary intervention 74
Impact of COVID-19 Pandemic on Mechanical Reperfusion for Patients With STEMI 74
Resting Pd/Pa and haemodynamic relevance of coronary stenosis as evaluated by fractional flow reserve 72
Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation 70
Impact of statin therapy on the immature platelet count in patients with coronary artery disease: A single centre cohort study 63
Ticagrelor in the prevention of coronary and non-coronary atherothrombotic events: A comprehensive meta-analysis of 10 randomized trials 63
Navigating Cardiotoxicity in Immune Checkpoint Inhibitors: From Diagnosis to Long-Term Management 51
Totale 9.673
Salva come PNG Salva come JPEG
Categoria #
all - tutte 47.558
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.558
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022401 0 0 0 34 47 7 15 13 32 29 105 119
2022/20231.278 92 52 85 6 108 107 25 85 645 3 45 25
2023/2024448 30 40 35 6 69 0 48 7 1 4 142 66
2024/2025739 23 15 23 2 41 5 81 128 189 73 10 149
2025/20263.596 168 120 273 603 302 258 629 612 188 224 156 63
2026/2027977 135 348 240 254 0 0 0 0 0 0 0 0
Totale 9.673